Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S. Subsidiary, CLS Americas Inc
03. Januar 2022 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS AB) (Stockholm: CLS B), developer of high precision, image-guided focal laser ablation (FLA) systems,...
CLS and Toronto General Hospital Resume Clinical Trial for Prostate Cancer as Company Receives Approval for Updated Sterilization Process by Health Canada
12. Juli 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced it has...
CLS and Toronto General Hospital Resume Clinical Trial for Prostate Cancer as Company Receives Approval for Updated Sterilization Process by Health Canada
12. Juli 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 12, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced it has received...
CLS Americas Continues Clinical Collaborations from New West Coast Office at Spectrum Office Plaza in Irvine, CA
14. Januar 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced it has relocated its U.S. headquarters to a new office in the Irvine Spectrum Office...
CLS and Toronto General Hospital Continue Clinical Trial Collaboration Regarding MRI-Guided Laser Ablation Treatment of Prostate Cancer
17. November 2020 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the clinical study performed in collaboration with Toronto General Hospital, Canada,...
CLS Americas Highlights High-Precision, Image-Guided Laser Ablation System for Prostate Tumors and Soft Tissues at FOCAL2020 Virtual Conference
29. September 2020 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS Americas), a subsidiary of CLS AB in Lund, Sweden, today announced it will be participating in...
University Hospital in Germany Evaluates CLS TRANBERG® | Laser Thermal Therapy System for Minimally Invasive Treatment of Small Liver Metastases and Tumors
18. März 2020 11:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, March 18, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) today announced that the University Hospital in Magdeburg, Germany is evaluating the company’s MR-guided,...
CLS Presents Image-Guided Laser Thermotherapy Enhancements at ESIR - European School of Interventional Radiology Conference
10. Dezember 2019 03:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
INNSBRUCK, Austria, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) will present its high precision, image-guided TRANBERG® | Laser Thermal Therapy System, new...
Desert Medical Imaging Doctors Presented Interim Clinical Study Results of MR-guided FLA Treatment of MR-visible Prostate Cancer at AdMeTech 4th Global Summit
08. Oktober 2019 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) today announced that Bernadette M. Greenwood, BSc, PG Cert., RT(R)(MR) and John F. Feller, M.D. of Desert...
CLS Presents Poster on “Laser Thermal Therapy for Brain Metastases” at 9th Annual Brain Mets Congress in Marseille, France
02. Oktober 2019 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present a poster at the 9th Annual Brain Metastases Research and Emerging...